Anemia Working Group Romania Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00551603
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Anemia Workiing Group Romania

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Diabetes Mellitus (Phase 4)

Heart Failure (Phase 3)

Kidney Diseases (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6